SARS-CoV-2 S Glycoprotein Stabilization Strategies - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Viruses Année : 2023

SARS-CoV-2 S Glycoprotein Stabilization Strategies

SARS-CoV-2 S Glycoprotein Stabilization Strategies.

Résumé

The SARS-CoV-2 pandemic has again shown that structural biology plays an important role in understanding biological mechanisms and exploiting structural data for therapeutic interventions. Notably, previous work on SARS-related glycoproteins has paved the way for the rapid structural determination of the SARS-CoV-2 S glycoprotein, which is the main target for neutralizing antibodies. Therefore, all vaccine approaches aimed to employ S as an immunogen to induce neutralizing antibodies. Like all enveloped virus glycoproteins, SARS-CoV-2 S native prefusion trimers are in a metastable conformation, which primes the glycoprotein for the entry process via membrane fusion. S-mediated entry is associated with major conformational changes in S, which can expose many off-target epitopes that deviate vaccination approaches from the major aim of inducing neutralizing antibodies, which mainly target the native prefusion trimer conformation. Here, we review the viral glycoprotein stabilization methods developed prior to SARS-CoV-2, and applied to SARS-CoV-2 S, in order to stabilize S in the prefusion conformation. The importance of structure-based approaches is highlighted by the benefits of employing stabilized S trimers versus non-stabilized S in vaccines with respect to their protective efficacy.

Dates et versions

hal-04025453 , version 1 (12-03-2023)

Identifiants

Citer

Borys Pedenko, Guidenn Sulbaran, Delphine Guilligay, Gregory Effantin, Winfried Weissenhorn. SARS-CoV-2 S Glycoprotein Stabilization Strategies. Viruses, 2023, 15 (2), pp.558. ⟨10.3390/v15020558⟩. ⟨hal-04025453⟩
63 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More